Impartial advisers to the U.S. Facilities for Illness Management and Prevention will meet later this month to make suggestions on booster doses of Moderna Inc and Johnson & Johnson’s COVID-19 vaccines, the company mentioned on Friday.
The conferences, on October 20-21, are scheduled every week after advisers to the U.S. Meals and Drug Administration weigh in on the necessity for booster doses of the 2 vaccines.
The CDC panel, known as Advisory Committee on Immunization Practices, may also focus on COVID-19 vaccines for youngsters on Nov. 2 and three, an company spokesperson mentioned.
The pediatric conferences are additionally scheduled every week after FDA advisers evaluation the necessity for Pfizer Inc’s COVID-19 vaccine in kids aged 5 to 11.
Pfizer on Thursday mentioned the corporate and its accomplice BioNTech SE have requested U.S. regulators to authorize emergency use of their COVID-19 vaccine for youngsters ages 5 to 11. (Reporting by Manas Mishra and Manojna Maddipatla in Bengaluru; Modifying by Shounak Dasgupta and Shinjini Ganguli)
© 2021 Thomson/Reuters. All rights reserved.